Author:
Pillai Venkateswaran C.,Venkataramanan Raman,Parise Robert A.,Christner Susan M.,Gramignoli Roberto,Strom Stephen C.,Rudek Michelle A.,Beumer Jan H.
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmaceutical Science,Pharmacology
Reference54 articles.
1. A drug-drug interaction study to evaluate the effect of rifampicin on the pharmacokinetics of the EGF receptor tyrosine kinase inhibitor, erlotinib, in healthy subjects;Abbas;Proc Am Soc Clin Oncol,2003
2. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine
3. Pharmacokinetic Considerations for New Targeted Therapies
4. Without Therapeutic Drug Monitoring, There Is No Personalized Cancer Care
5. Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs;Boffito;Antivir Ther,2005
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献